Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Topical cyclosporin A may help treat psoriasis but has absorption and side effect challenges.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Methotrexate plus prednisolone had the fewest serious side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Topical 1% pimecrolimus effectively treated alopecia areata.